Webcasting is the most cost-effective way for a single user or a group to view LIVE or archived meetings.
By using streaming technology we broadcast from the FDA meeting right to your desktop or mobile device, to unlimited locations, globally. Our cameras focus in on the committee, the presenters and their presentations while sending video and audio live to your desktop. We offer single viewer and group options. If you would like to broadcast a meeting to your group - purchase a "group" license and simply hook up your network connected PC and project your image in your conference room or auditorium.
Stream Quality: Excellent
Single Viewer License (One Viewer | One PC): Allows for a single viewer to view the webcast on their desktop. Cost: $250
Group License (Single Conference Room Feed): Allows for a fullscreen viewing for meeting rooms, auditoriums. Cost: $1,000
Standard Browser on a PC, MAC or Mobile with Internet Access.
- Oncologic Drugs Advisory Committee
Meeting Date: 2/9/21-2/9/21
The committee will discuss supplemental biologics license application (sBLA) 125514/s-089, for KEYTRUDA (pembrolizumab), submitted by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. The proposed indication (use) for this product is for the treatment of patients with high-risk, early-stage triple-negative breast cancer, in combination with chemotherapy as neoadjuvant treatment, then as a single agent as adjuvant treatment after surgery. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.
|Location:||Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform.||Related News Links:||Not Available|